|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
The Immunex Alumni, Hood Wins Russ Prize, Williams Grabs Biogen Gig, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
01/06/11 |
Seattle
|
|
Omeros Gets Drugs for Bleeding
|
Luke Timmerman |
01/05/11 |
Seattle
|
|
ZymoGenetics CEO Doug Williams Exits the Stage, Mulls Next Free Agent Move
|
Luke Timmerman |
11/08/10 |
Seattle
|
|
ZymoGenetics Regains Full U.S. Rights to Recothrom as Bayer Walks Away
|
Luke Timmerman |
12/21/09 |
Seattle
|
|
Zymo Drug Gets Canadian Approval
|
Luke Timmerman |
12/16/09 |
Seattle
|
|
Zymo Application Yanked in EU
|
Luke Timmerman |
12/14/09 |
Seattle
|
|
ZymoGenetics, King Pharma Brawl Over Drugs to Control Surgical Bleeding
|
Luke Timmerman |
11/09/09 |
Seattle
|
|
ZymoGenetics’ Former Medical Boss Leads Rival Startup, ProFibrix, With Drug For Bleeding
|
Luke Timmerman |
10/26/09 |
Seattle
|
|
ZymoGenetics Plays Hardball, Targeted Genetics’ Legacy, Omeros Preps for Fall IPO, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
08/27/09 |
Seattle
|
|
ZymoGenetics, Citing Two Patient Deaths, Builds Up Ammunition for Case Against Rival
|
Luke Timmerman |
08/20/09 |
Seattle
|
|
ZymoGenetics Plays Hardball, Asks FDA to Pull Competing Drug Off Market Because of Safety
|
Luke Timmerman |
08/20/09 |
Seattle
|
|
Zymo Gets $6M in Q2 Recothrom Sales
|
Luke Timmerman |
08/03/09 |
Seattle
|
|
Dendreon’s Hiring Binge, Calistoga’s Venture Round, ZymoGenetics Unloads Drugs, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
05/07/09 |
Seattle
|
|
ZymoGenetics Drug Sales Still Slumping After Full Year on Market
|
Luke Timmerman |
05/05/09 |
Seattle
|
|
ZymoGenetics Clamps Down on Losses, Predicts Climbing Recothrom Sales
|
Luke Timmerman |
02/11/09 |
Seattle
|
|
ZymoGenetics’ New Boss Sees Parallels to Dark Days at Immunex
|
Luke Timmerman |
01/05/09 |
Seattle
|
|
ZymoGenetics Drug For Surgical Bleeding Demonstrates Safety in Trial
|
Luke Timmerman |
12/08/08 |
Seattle
|
|
ZymoGenetics Cash Gets Lean, Recothrom Sales Still Slow
|
Luke Timmerman |
11/04/08 |
Seattle
|
|
ZymoGenetics Drug For Hepatitis C Kills Virus with Minimal Side Effects
|
Luke Timmerman |
11/03/08 |
Seattle
|
|
ZymoGenetics, Bayer Drug Vying for European Regulatory Approval
|
Luke Timmerman |
09/02/08 |
Seattle
|
|
ZymoGenetics Drug Getting Off to Slow Start in Marketplace
|
Luke Timmerman |
08/06/08 |
Seattle
|
|
ZymoGenetics Receives $100 Million Commitment From Deerfield
|
Luke Timmerman |
06/30/08 |
Seattle
|
|
Page 1 of
1 |
|
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.
